This is where other options such as Temps, or perhaps startups you could invest in, or Eli Lilly become very interesting. Because it's not just a company like Moderna that works in this kind of thing.
TEM — All updates
4 entries loaded; 0 direction changes
I bought a little bit of TEM today, because it seems to hold up quite well . It had this earlier resistance, which now serves as support. It incorporates the rising 20-day moving average.
It rose at high volume and consolidates at low volume. 28% of the stock is short, uh you know, the float is short. Pelosi has, you know, 5% of her portfolio in this name. So, I have a little bit and only a little bit, because it is quite unpredictable.
If it can pick up a bit and the sector gains some strength , particularly mRNA, which, you know, set the sector ablaze , it is still accepting... I have to say, it is still accepting, not that it is struggling, but it is still accepting these higher prices up here.
And just, you know, the good news is that the bandwidth is narrowing, and maybe that means it's ready for a move soon. This is probably the, you know, the driving force for this group that wants to get moving, but I just find the way TEM has held up best so far pleasant.
Um, and as I said, I have a small starting position and there are some other names in there who, uh, you know, don't look that good.
We should probably keep a close eye on TEM stock this week. It lies precisely at the 20-day upward moving average, which is the anchor from the low, and at this previous resistance range.
Therefore, TEM stock looks interesting. I would just like to see it settle down a bit before thinking about getting into it.
TEM breaking right back down to the breakout point. It's a squirrely stock to begin with.